Advanced Enzyme Technologies Limited specializes in Biotechnology within the Healthcare sector.
Advanced Enzyme Technologies Limited, with Security Code 540025, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.
| Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
|---|---|---|---|---|---|---|---|---|---|
| 2024-01-01 | 2024-03-31 | 1,578.15 | 298.72 | 1,673.14 | 2.53 | -344.50 | 94.99 | -92.76 | 396.10 |
| 2024-01-01 | 2024-03-31 | 924.03 | 31.38 | 956.13 | 0.28 | -187.32 | 32.10 | -30.67 | 103.91 |
| 2023-10-01 | 2023-12-31 | 911.41 | 191.20 | 947.06 | 1.71 | -203.29 | 35.65 | -27.15 | 253.56 |
| 2023-10-01 | 2023-12-31 | 1,609.35 | 425.02 | 1,753.31 | 3.74 | -399.85 | 143.96 | -86.04 | 588.77 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 28% |
| 3 Years: | 20% |
| TTM: | 120% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 17% |
| 3 Years: | -3% |
| 1 Year: | 30% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 8% |
| 3 Years: | 8% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 5% |
| 3 Years: | 0% |
| TTM: | 34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 17% |
| 3 Years: | -3% |
| 1 Year: | 30% |
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES) today announced its financial results for the quarter ended June 30, 2023. The Company reported a revenue of Rs. 121.44 crore for the quarter, a growth of 12.3% over the same period last year.
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES) today announced that it has entered into a strategic partnership with a leading global enzyme producer. The partnership will focus on the development and commercialization of innovative enzyme solutions for various industries.
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES) today announced that it has received the prestigious 'Enzyme Company of the Year' award at the 2023 Industry Awards. The award recognizes the Company's significant contributions to the enzyme industry.
The patent covers the company's proprietary technology for immobilizing glucose oxidase enzyme on a solid support, which enhances its stability and performance in various applications.
